Erythrocyte transfusion causes immunosuppression after total hip replacement

Susan J.H. Kendall, Justin Weir, Richard Aspinall, Don Henderson, John Rosson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A prospective study of 34 patients undergoing total hip replacement was done to determine whether homologous erythrocyte transfusion causes postoperative immunosuppression. In the transfused patient group (14 patients), there was a reduction in CD3+ and CD3+4+ cell numbers at Day 2, returning to preoperative levels by Day 7. In contrast, in the untransfused patient group (20 patients), there was no significant depression in these lymphocyte subgroups at Day 2 and an increase in total lymphocyte, CD3+, CD3+4+, and CD3+4-8- cell numbers at Day 7. In both patient groups there was postoperative leukocytosis, granulocytosis, and monocytosis at Days 2 and 7, with no significant change in postoperative B (CD19+) cell numbers, natural killer cells, or the minor T cell populations of CD3+4+8+ and CD3+25+. The lymphocyte functional test of Candida recall was significantly impaired at Day 7 in the transfused patient group, where Candida recall is a memory T cell response to an antigen extracted from the yeast Candida Albicans. These findings suggest that homologous erythrocyte transfusion after hip replacement surgery causes cell mediated immune suppression. The main clinical implication of the current study is that perioperative homologous erythrocyte transfusion may place patients at greater risk of infectious complications, including infection of the prosthesis.

Original languageEnglish
Pages (from-to)145-155
Number of pages11
JournalClinical Orthopaedics and Related Research
Volume381
Publication statusPublished - Dec 2000
Externally publishedYes

Fingerprint

Erythrocyte Transfusion
Hip Replacement Arthroplasties
Immunosuppression
Cell Count
Lymphocytes
Candida
T-Lymphocytes
Leukocytosis
Candida albicans
Natural Killer Cells
Prostheses and Implants
Hip
Yeasts
Prospective Studies
Antigens
Infection

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Erythrocyte transfusion causes immunosuppression after total hip replacement. / Kendall, Susan J.H.; Weir, Justin; Aspinall, Richard; Henderson, Don; Rosson, John.

In: Clinical Orthopaedics and Related Research, Vol. 381, 12.2000, p. 145-155.

Research output: Contribution to journalArticle

Kendall, Susan J.H. ; Weir, Justin ; Aspinall, Richard ; Henderson, Don ; Rosson, John. / Erythrocyte transfusion causes immunosuppression after total hip replacement. In: Clinical Orthopaedics and Related Research. 2000 ; Vol. 381. pp. 145-155.
@article{8872ede6b69a48a18171db673014dc48,
title = "Erythrocyte transfusion causes immunosuppression after total hip replacement",
abstract = "A prospective study of 34 patients undergoing total hip replacement was done to determine whether homologous erythrocyte transfusion causes postoperative immunosuppression. In the transfused patient group (14 patients), there was a reduction in CD3+ and CD3+4+ cell numbers at Day 2, returning to preoperative levels by Day 7. In contrast, in the untransfused patient group (20 patients), there was no significant depression in these lymphocyte subgroups at Day 2 and an increase in total lymphocyte, CD3+, CD3+4+, and CD3+4-8- cell numbers at Day 7. In both patient groups there was postoperative leukocytosis, granulocytosis, and monocytosis at Days 2 and 7, with no significant change in postoperative B (CD19+) cell numbers, natural killer cells, or the minor T cell populations of CD3+4+8+ and CD3+25+. The lymphocyte functional test of Candida recall was significantly impaired at Day 7 in the transfused patient group, where Candida recall is a memory T cell response to an antigen extracted from the yeast Candida Albicans. These findings suggest that homologous erythrocyte transfusion after hip replacement surgery causes cell mediated immune suppression. The main clinical implication of the current study is that perioperative homologous erythrocyte transfusion may place patients at greater risk of infectious complications, including infection of the prosthesis.",
author = "Kendall, {Susan J.H.} and Justin Weir and Richard Aspinall and Don Henderson and John Rosson",
year = "2000",
month = "12",
language = "English",
volume = "381",
pages = "145--155",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Erythrocyte transfusion causes immunosuppression after total hip replacement

AU - Kendall, Susan J.H.

AU - Weir, Justin

AU - Aspinall, Richard

AU - Henderson, Don

AU - Rosson, John

PY - 2000/12

Y1 - 2000/12

N2 - A prospective study of 34 patients undergoing total hip replacement was done to determine whether homologous erythrocyte transfusion causes postoperative immunosuppression. In the transfused patient group (14 patients), there was a reduction in CD3+ and CD3+4+ cell numbers at Day 2, returning to preoperative levels by Day 7. In contrast, in the untransfused patient group (20 patients), there was no significant depression in these lymphocyte subgroups at Day 2 and an increase in total lymphocyte, CD3+, CD3+4+, and CD3+4-8- cell numbers at Day 7. In both patient groups there was postoperative leukocytosis, granulocytosis, and monocytosis at Days 2 and 7, with no significant change in postoperative B (CD19+) cell numbers, natural killer cells, or the minor T cell populations of CD3+4+8+ and CD3+25+. The lymphocyte functional test of Candida recall was significantly impaired at Day 7 in the transfused patient group, where Candida recall is a memory T cell response to an antigen extracted from the yeast Candida Albicans. These findings suggest that homologous erythrocyte transfusion after hip replacement surgery causes cell mediated immune suppression. The main clinical implication of the current study is that perioperative homologous erythrocyte transfusion may place patients at greater risk of infectious complications, including infection of the prosthesis.

AB - A prospective study of 34 patients undergoing total hip replacement was done to determine whether homologous erythrocyte transfusion causes postoperative immunosuppression. In the transfused patient group (14 patients), there was a reduction in CD3+ and CD3+4+ cell numbers at Day 2, returning to preoperative levels by Day 7. In contrast, in the untransfused patient group (20 patients), there was no significant depression in these lymphocyte subgroups at Day 2 and an increase in total lymphocyte, CD3+, CD3+4+, and CD3+4-8- cell numbers at Day 7. In both patient groups there was postoperative leukocytosis, granulocytosis, and monocytosis at Days 2 and 7, with no significant change in postoperative B (CD19+) cell numbers, natural killer cells, or the minor T cell populations of CD3+4+8+ and CD3+25+. The lymphocyte functional test of Candida recall was significantly impaired at Day 7 in the transfused patient group, where Candida recall is a memory T cell response to an antigen extracted from the yeast Candida Albicans. These findings suggest that homologous erythrocyte transfusion after hip replacement surgery causes cell mediated immune suppression. The main clinical implication of the current study is that perioperative homologous erythrocyte transfusion may place patients at greater risk of infectious complications, including infection of the prosthesis.

UR - http://www.scopus.com/inward/record.url?scp=0033659481&partnerID=8YFLogxK

M3 - Article

VL - 381

SP - 145

EP - 155

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

ER -